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Abstract
 
Chlamydia
 
 are obligate intracellular bacteria that replicate in a vacuole inside a host cell.
Chlamydial infection has been shown to protect the host cell against apoptotic stimuli. This is
likely important for the ability of 
 
Chlamydia
 
 to reproduce in human cells. Here we show that
resistance to apoptosis is conveyed by the destruction of the proapoptotic BH3-only proteins
Bim/Bod, Puma, and Bad during infection. Apoptotic stimuli were blocked upstream of the
mitochondrial activation of Bax/Bak. During infection with both species, 
 
Chlamydia trachomatis
 
and 
 
Chlamydia pneumoniae
 
, Bim protein gradually disappeared without noticeable changes in
Bim mRNA. The disappearance was blocked by inhibitors of the proteasome. Infected cells re-
tained sensitivity to Bim expressed by transfection, indicating functional relevance of the Bim
disappearance. Fusion to Bim targeted the green fluorescent protein for destruction during in-
fection. Analysis of truncation mutants showed that a short region of Bim containing the BH3
domain was sufficient for destruction during chlamydial infection. Like Bim, Puma and Bad
proteins disappeared during infection. These results reveal a novel way by which microbes can
interfere with the host cell’s apoptotic machinery, and provide a molecular explanation of the
cellular resistance to apoptosis during infection with 
 
Chlamydia
 
.
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Introduction
 
Infections with bacteria of the genus 
 
Chlamydia
 
 are a common
cause of human disease. Among these, 
 
Chlamydia trachomatis
 
is of great importance as the cause of eye infections and
sexually transmitted diseases (1), whereas 
 
Chlamydia pneu-
moniae
 
 is a common agent of respiratory infections (2).
 
Chlamydia
 
 are obligate intracellular bacteria and replicate
within a cytosolic vacuole in eukaryotic cells. Although
contained within an occluded vacuole, 
 
Chlamydia
 
 can impact
on host cell function in various ways.
Cell death by apoptosis is the result of the activation of
an intracellular signal transduction pathway. It is becoming
increasingly clear that apoptosis plays an important role in
the defense against pathogens (3, 4) on the level of both the
reaction of an individual host cell to an invading microor-
ganism and the reacting immune system. For instance, in
viral infections apoptosis is likely to act as a cellular defense
mechanism. This is suggested by the finding that many viruses
carry genes whose products inhibit apoptosis (5, 6). A
number of bacteria have been found to induce apoptosis in
the host’s cells (for instance 
 
Legionella
 
 and 
 
Shigella
 
; refer-
ences 7 and 8). By contrast, a number of earlier studies
have found that 
 
Chlamydia
 
 can decrease sensitivity of an in-
fected cell against apoptotic stimuli (9–12).
The molecular function of the apoptotic pathway has
been worked out in some detail. The final events of apoptosis
are executed by the caspase proteases (13). In most circum-
stances, caspase activation requires the release of cyto-
chrome c from the mitochondria into the cytosol (14). This
release is governed by the Bcl-2 family of proteins. Bcl-2
proteins can be structurally and functionally divided into
the following three groups: inhibitors of apoptosis (Bcl-2,
Bcl-x, and others), effectors of cytochrome c release (Bax,
Bak, and Bok), and triggers of apoptosis (BH3-only proteins).
According to a plausible model, a stimulus to apoptosis acti-
vates one or several BH3-only proteins (nine are known at
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present; reference 15) that in turn activates Bax/Bak by an
unknown mechanism. Active Bax/Bak then effect the re-
lease of cytochrome c. Bcl-2 blocks apoptosis by sequester-
ing active BH3-only proteins (15).
Earlier studies have begun to map the apoptosis-inhibi-
tory activity from 
 
Chlamydia
 
 within the apoptotic appara-
tus. 
 
Chlamydia
 
 efficiently block the release of cytochrome c
from mitochondria upon the induction of apoptosis by
external stimuli (9), whereas a death receptor signal that
induces apoptosis independently of mitochondria is not
inhibited (16). Here, we describe a molecular characteriza-
tion of the apoptosis-inhibitory activity of 
 
Chlamydia
 
 in
human host cells. We first focused on the BH3-only pro-
tein Bim, in part because Bim is bound to the microtubuli
cytoskeleton, which is substantially reorganized during
chlamydial infection (17). We found evidence that Bim is
targeted for proteasomal destruction during chlamydial
infection and extend this observation to the BH3-only
proteins Puma and Bad. Because infected cells were not
protected against active Bim or Puma, the disappearance of
these proteins likely is the reason for the resistance of in-
fected cells against apoptosis.
 
Materials and Methods
 
Cell Lines, Bacterial Organisms, and Infection.
 
The human la-
ryngeal carcinoma cell line Hep2, the human cervical adenocarci-
noma cell line HeLa, the human T lymphocyte cell line Jurkat,
the pro-myeloblastic/myelocytic cell line HL60, and the human
breast cancer cell line MCF-7 were obtained from the American
Type Culture Collection (ATCC). The cell line HeLa Trex,
which stably expresses the tetracycline repressor, was purchased
from Invitrogen. All cells were cultured in either DMEM or
RPMI 1640 complemented with 10% FCS. The mycoplasma-
free strains 
 
C. pneumoniae
 
 strain CM-1 (VR-1360) and 
 
C. tra-
chomatis
 
 strain L2 were obtained from ATCC. 
 
Chlamydia
 
 were
grown in Hep2 cells and purified as described previously (11, 16).
Human cells were infected with 
 
C. trachomatis
 
 or C. 
 
pneumoniae
 
 at
a multiplicity of infection (MOI) of 3 unless otherwise men-
tioned (11, 16). Infection was checked routinely and was found
to be 
 
 
 
95% in the experiments shown. 
 
Legionella pneumophila
2064
 
 was obtained from P. Hoffmann (Dalhousie University,
Halifax, Canada; reference 18) and grown on BCYE plates. For
infection of host cells with 
 
Legionella
 
, a bacterial suspension in cell
culture medium (McFarland 2 tubidity standard) was prepared
and incubated with the cells for 8 h.
 
Induction of Apoptosis.
 
Host cells (3 
 
  
 
10
 
5
 
/well in 6-well
plates seeded the day before) were infected or not and subjected
to UV irradiation. Cells were washed with PBS and then exposed
to UV light (1,000 J/m
 
2
 
) in a transilluminator box (cells were
 
 
 
80% confluent at this point; Stratagene). Medium was added
and cells were analyzed at the time points given.
 
Assay for Nuclear Apoptosis and Caspase Activity.
 
Apoptosis
was detected as described previously (11, 16). In brief, for detec-
tion of nuclear apoptosis, cells were stained with 20 
 
 
 
M Hoechst
33258 (Sigma-Aldrich) for 30 min and nuclear morphology was
assessed under a fluorescence microscope. 300 nuclei per sample
were scored. For detection of caspase 3–like activity, cells were
lysed in NP-40 lysis buffer (11, 16), triplicates of aliquots were
added to a peptide containing 10 
 
 
 
M of a caspase 3 recognition
sequence (DEVD-AMC) in assay buffer containing BSA, Hepes,
and fluorimetric substrate. Free AMC was measured after 1 h of
incubation at 37
 
 
 
C and values are presented as arbitrary relative
fluorescence units (mean 
 
  
 
the SD of triplicate reactions).
 
Microscopy.
 
Hep2 cells were grown on glass coverslips, in-
fected with 
 
C. trachomatis
 
 or left uninfected, and some samples
were treated with UV light for apoptosis induction as described
above. Cells were fixed with 2% formalin for 30 min and consec-
utively stained with mouse anti–cytochrome c mAb (Becton
Dickinson), FITC- or Cy3-labeled anti–mouse antiserum, and
Alexa Fluor 546–labeled mouse antichlamydial LPS antibody
(Progen) in PBS containing 1% FCS and 1% saponin. For detec-
tion of active Bax, cells were stained with anti-active Bax mAb
(6A7; Upstate Biotechnology; reference 19) and Cy3-labeled
anti–rabbit antiserum (Dianova) followed by staining with Mi-
toTracker Green FM (Molecular Probes) or antichlamydial LPS
antibody. Pictures were obtained with a laser scanning micro-
scope (Carl Zeiss MicroImaging, Inc.). For detection of apoptosis
in infected and transfected cells, HeLa cells were infected and
transfected as described above. Cells were fixed and stained as de-
scribed above (antichlamydia and Hoechst). Pictures were taken
under a Zeiss microscope and analyzed with Zeiss AxioVision
software. Brightness of whole pictures was adjusted electronically.
 
Determination of Bim mRNA by Microarrays.
 
HeLa cells were
infected with 
 
C. trachomatis
 
 or 
 
C. pneumoniae.
 
 mRNA was harvested
at various time points as indicated (see Results) and analyzed by a
human micro array (U95A; Affymetrix, Inc.) as described recently
in detail (20). Bim is represented on the chip by the sequence code
31611_s_at and the GenBank accession no. AF032457.
 
Detection of Bax and Bak by Flow Cytometry.
 
HeLa cells were
infected with 
 
C. trachomatis
 
 or not and apoptosis was induced as
described above. For some experiments, apoptosis was induced
by transfection with expression vectors for enhanced GFP (EGFP)
and Bim
 
S 
 
10 h after infection. Cells were harvested by trypsiniza-
tion and stained for active Bax or Bak. Anti-active Bak (amino
acids 1–24) was purchased from Oncogene Research Products.
Flow cytometry was performed with a FACSCalibur (Becton
Dickinson). At least 10
 
5 
 
cells per sample were recorded.
 
Transfection of HeLa Cells.
 
HeLa cells were plated in 12-well
plates (2 
 
  
 
10
 
5 
 
per well) and infected with 
 
C. trachomatis
 
 as indi-
cated. At the time points shown in the figure legends, cells were
transfected in triplicate with 3 
 
 
 
g of control vector pEF, pEF-
Bim
 
S 
 
expression vector, or Puma expression vector (provided by
D. Huang, The Walter and Eliza Hall Institute of Medical Re-
search, Melbourne, Australia) together with 0.5 
 
 
 
g CMV-LacZ
using ethylene imine polymer solution (Fluka; reference 21). Af-
ter 3 h, medium was changed and 12–20 h later cells were stained
for 
 
 
 
-galactosidase activity. Blue cells were viewed under a mi-
croscope and scored alive or dead using morphological criteria
(22). For inducible expression, Bim
 
S 
 
and Puma were cloned by
PCR into the vector pCDNA4/TO. When transfected into cells
that stably express the tetracycline repressor, the expression can
be induced by removal of the suppressor upon the addition of
tetracycline. The cell line HeLa Trex was transfected with these
constructs or the empty vector, infected, and after 24 h the ex-
pression of Bim
 
S 
 
or Puma was induced by the addition of tetracy-
cline. 20 h later, cells were scored as described above.
 
Western Blot Analysis.
 
For Western blot analysis, various cell
types were either infected with 
 
C. trachomatis
 
, 
 
C. pneumoniae
 
, or 
 
L.
pneumophila 2064
 
, or left uninfected and harvested at the indicated
time points. In some experiments, cells were treated with 10 
 
 
 
g/
ml rifampin or 500 nM proteasome inhibitor MG132 (Calbio-
chem). For SDS extracts, 4 
 
  
 
10
 
5 
 
cells were directly lysed in SDS-
containing loading buffer. For detergent extracts, 5 
 
  
 
10
 
5 
 
cells 
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were lysed by incubation in 50 
 
 
 
l Triton buffer (1% Triton
X-100, 0.05 M Pipes-NaOH, 0.05 M Hepes, pH 7.0, 2 mM
MgCl
 
2
 
, 1 mM EDTA, 10 mM DTT, and protease inhibitors;
Roche) for 30 min on ice. After centrifugation at 2,000 
 
g
 
 at 4
 
 
 
C
for 10 min, loading buffer was added and lysates were run on a
12% polyacrylamide gel. Proteins were transferred to nitrocellulose
membranes, and membranes were probed with antibodies specific
for Bax, Bak (Upstate Biotechnology), Bim (polyclonal from rab-
bit; Sigma-Aldrich), chlamydial Hsp60 (Affinity BioReagents, Inc.),
GST (monoclonal from mouse; provided by H. Flaswinkel, GSF,
Neuherberg, Germany), Puma NH
 
2 
 
terminus (rabbit; Sigma-
Aldrich), tubulin (Sigma-Aldrich), Bad (Cell Signaling Technol-
ogy), or GFP (CLONTECH Laboratories, Inc.). Proteins were vi-
sualized using peroxidase-conjugated secondary antibodies and a
chemiluminescence detection system (PerkinElmer).
 
Measurement of Proteasomal Activity and In Vitro Bim Degrada-
tion.
 
Hep2 cells were infected with 
 
C. trachomatis
 
 or left unin-
fected. After 24 h of infection, cytosolic extracts were prepared as
described previously (11). In brief, cells were resuspended in a
cytoplasmic extraction buffer (1 mM Na-EGTA, 1 mM Na-
EDTA, 1.5 mM MgCl
 
2
 
, 10 mM KCl, 20 mM Hepes-KOH, pH
7.5) containing a proteinase inhibitor mix and 1 mM DTT. After
incubation for 1 h on ice, cells were disrupted by passages
through a 22-gauge needle. For measurement of proteasomal ac-
tivity, reactions were set up to contain 400 
 
 
 
g of cytosolic extract
in a total of 200 
 
 
 
l of assay buffer (20 mM Tris/HCl, pH 7.5, and
50 mM NaCl) containing a final concentration of 10 
 
 
 
M Suc-
LLVY-AMC fluorimetric substrate (proteasome substrate; Bachem).
Free AMC was measured at 390 nm (excitation) and 440 nm (emis-
sion) every 5 min over 35 min.
GST-Bim
 
EL 
 
(provided by D. Huang) was expressed in 
 
Esche-
richia coli
 
 and purified using standard protocols. GST-CED-4 pro-
tein was provided by B. Seiffert (Technical University Munich,
Munich, Germany; reference 23). For assessment of proteolytic
activity, 400 
 
 
 
g of cytosolic extract was incubated with 0.8 
 
 
 
g
GST-Bim
 
EL
 
, 0.4 
 
 
 
g GST-CED-4, and 500 
 
 
 
M of proteasome
inhibitor MG132 for 1.5 h at 37
 
 
 
C. Western blot analysis was
performed as described above.
 
Assay for Degradation of GFP-Bim
 
L 
 
Mutants.
 
Bim
 
L 
 
was fused to
the COOH terminus of EGFP in the vector pEGFP-C1. A number
of Bim fragments were generated by PCR and cloned into pEGFP-
C2 as COOH-terminal fusions to EGFP (BD Biosciences; details
about the cloning procedure are available from the authors upon re-
quest). Integrity of PCR products was confirmed by sequencing.
Hep2 cells were transfected with the constructs by electroporation
(5 
 
  
 
10
 
6 
 
cells with 20 
 
 
 
g DNA at 280 V, 960 
 
 
 
F). Some aliquots
were infected with 
 
C. trachomatis
 
 after 4 h. In some experiments,
cells were treated with 500 nM of proteasome inhibitor MG132
(Calbiochem) or 10 
 
 
 
M lactacystin (BIOMOL Research Laborato-
ries, Inc.). 20 h after infection, cells were harvested and GFP fluo-
rescence was detected by flow cytometry with a FACSCalibur
(Becton Dickinson). At least 10
 
5 
 
cells per sample were recorded.
 
Online Supplemental Material
 
Fig. S1 shows micrographs of
Hoechst staining of normal or infected cells upon UV irradiation.
Fig. S2 demonstrates the inhibition of taxol-induced apoptosis by
chlamydial infection. The photos provided in Fig. S3 show the
morphology of cells (normal or infected) transfected with an ex-
pression vector for Puma. Fig. S4 gives data that show that
chlamydial infection also fails to protect cells against short-term
(6-h) induction of Bim
 
S 
 
through tetracyclin. Fig. S5 demonstrates
that transfection of Bim
 
S 
 
causes the mitochondrial release of cyto-
chrome c also in infected cells. Figs. S1–S5 are available at http://
www.jem.org/cgi/content/full/jem.20040402/DC1.
 
Results
 
Chlamydia Inhibit UV Light–induced Nuclear Apoptosis, Ef-
fector Caspase Activation, and Cytochrome C Release.
 
We
chose to study apoptosis induced by UV irradiation in epi-
theloid cells infected with 
 
Chlamydia
 
 because this pathway
to apoptosis is well investigated and can therefore be stud-
ied closely. Infection with 
 
Chlamydia
 
 has been found to in-
Figure 1. Infection with C. trachomatis or C. pneumoniae inhibits UV
light–induced apoptosis. Hep2 cells were infected with Chlamydia or not
(mock). After 24 (C. trachomatis) or 48 h (C. pneumoniae), apoptosis was
induced by UV irradiation (1,000 J/m2). 6 h later, cells were analyzed.
(A) Nuclear apoptosis and caspase 3–like activity. Cells were stained with
Hoechst dye and nuclear apoptosis was scored under a fluorescence mi-
croscope (top; at least 300 nuclei were counted per sample and values are
mean/SD of triplicates) or lysed, and DEVD cleaving activity was measured
in cell extracts (bottom; mean/SD of triplicate measurements). (B) Cyto-
chrome c release from mitochondria. Cells were stained for cytochrome c
(green) and chlamydial LPS (red), and analyzed by laser-scanning microscopy.
Arrows point at chlamydial inclusions in cells that have retained cyto-
chrome c in their mitochondria. Asterisks indicate noninfected cells with
typical apoptotic morphology and release of cytochrome c from mito-
chondria (the cytochrome c signal is diminished upon release). The figure
shows results typical of three independent experiments. 
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hibit apoptosis induced by a variety of external stimuli such
as staurosporine, etoposide, TNF, or anti-CD95 (9–11,
16). Where investigated, this block was associated with the
inhibition of cytochrome c release (9, 11, 16). Although
probably most or all stimuli to mitochondrial apoptosis act
by activation of BH3-only proteins, it is unclear in most
cases which BH3-only protein implements which apop-
totic stimulus. It has, however, been shown that UV irradi-
ation induces apoptosis via the activation of Bim, and Bim-
dependent events of apoptosis have been described. UV
irradiation leads to the release of Bim from the cytoskeleton,
which translocates to the mitochondria and causes the acti-
vation of Bax. Active Bax in turn causes the release of cyto-
chrome c (24). We first tested whether Chlamydia are able
to inhibit apoptosis induced by UV irradiation. Hep2 cells
were infected with C. trachomatis or C. pneumoniae, or left
uninfected and subjected to UV irradiation. The morpho-
logical analysis of nuclear apoptosis 6 h later revealed the
expected protection by both chlamydial species. The sam-
ples not treated with UV light showed no difference be-
tween Chlamydia- and mock-infected cells (Fig. 1 A and
Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20040402/DC1). Detection of caspase activity by en-
zyme assay gave similar results. Upon UV irradiation, cas-
Figure 2. Activation of Bax and Bak by UV light is inhib-
ited in C. trachomatis–infected cells. (A) On the left, detection
of active Bax by flow cytometry is shown. HeLa cells were
either infected or left uninfected. At the time points indicated,
cells were treated with UV light (1,000 J/m2; bottom) or not
(top). Cells were collected 6 h later and stained for active
Bax. Normal line/shaded area, uninfected cells; bold line,
C. trachomatis–infected cells. On the right, detection of active
Bak is shown. Data are representative of three experiments.
(B) Detection of Bax and Bak by Western blot. HeLa cells
were infected or left uninfected. 24 or 48 h later, cells were
collected and subjected to Western blotting with antibodies
specific for total Bax, total Bak, chlamydial HSP60 (as a
control of infection), and tubulin (as a loading control).
Similar results were obtained in three independent experi-
ments. (C) Active Bax localizes to mitochondria and is
only detectable in noninfected cells. In Hep2 cells with or
without (mock) chlamydial infection, apoptosis was in-
duced by UV irradiation (1,000 J/m2). After 6 h, cells were
doubly labeled with anti-active Bax (red) and the mito-
chondrial marker MitoTracker Green FM (left, green;
colocalization results in yellow color) or anti-active Bax
(green) and anti-chlamydial LPS (right, red). Active Bax
was not detected in infected cells (arrows). Asterisks indi-
cate noninfected cells positive for active Bax. For the results
shown in the right panel, infectious dose was reduced
(MOI: 0.5). Similar results were obtained in three inde-
pendent experiments.Fischer et al. 909
pase 3–like activity and apoptosis were strongly reduced in
both C. trachomatis– and C. pneumoniae–infected cells com-
pared with noninfected cells (Fig. 1 A). No difference in
inhibition was seen when cycloheximide was included (not
depicted). Cytochrome c release upon UV irradiation was
further studied by immunostaining of cytochrome c. Sam-
ples not subjected to irradiation showed a typical mito-
chondrial pattern of cytochrome c in both mock- and
Chlamydia-infected cells. UV irradiation of uninfected cells
caused morphological changes and the release of cytochrome
c from mitochondria, resulting in a cytosolic distribution
and a reduction in intensity of cytochrome c staining (Fig.
1 B). Infected cells retained the typical mitochondrial pat-
tern of cytochrome c staining. Thus, chlamydial infection
blocks UV-induced apoptosis at the level or upstream of
cytochrome c release. Apoptosis induced by the cytotoxic
drug taxol, which depends on Bim (25), was also blocked
in infected cells (Fig. S2). UV irradiation was chosen for
the consecutive experiments because it acts much faster than
taxol, allowing finer analysis.
Figure 3. Chlamydia-infected
cells retain sensitivity to cell
death induced by overexpression
of BimS and Puma. (A) HeLa cells
were infected with C. trachomatis
or not (mock). 4 h after infection,
cells were transfected by lipofec-
tion with BimS expression vector
or control vector together with
CMV-LacZ. 3 h later, medium
was changed and 12 h later, cells
were stained for  -galactosidase
activity. Blue cells were viewed
under a microscope and scored
alive or dead. Examples of
chlamydial inclusions are illus-
trated with arrows. (B) Quantifi-
cation of dead and blue cells
(graphs show percentages of dead
cells; mean/SD of triplicate
wells). At least 300 cells per sample
were counted. On the top, HeLa
cells were infected with C. tra-
chomatis and transfected 8 h later.
20 h later, cells were stained for
 -galactosidase expression and
counted. This experiment was
performed three times with simi-
lar results. On the bottom, HeLa
cells stably expressing the tet re-
pressor were transfected with
reporter and a vector where the
expression of either BimS  or
Puma is placed under the control
of a tetracycline-inducible pro-
moter. 3 h later, some wells were
infected with C. trachomatis. 24 h
later, BimS/Puma expression was
induced by the addition of tetra-
cycline and cells were fixed and
stained as described above after
an additional 10 h. This experi-
ment was performed twice with
similar results. Although tetracy-
cline may inhibit the growth of
Chlamydia, our earlier results in-
dicate that the antiapoptotic activity is long-lived (it was still detectable after 48 h of rifampin treatment; reference 11). (C) BimS induces nuclear conden-
sation in cells infected with C. trachomatis. HeLa cells were infected with C. trachomatis at an MOI of 3 or mock infected as indicated. After 8 h, cultures
were cotransfected with EGFP and either empty vector or BimS expression constructs. 16 h later, cells were fixed and stained with antichlamydial LPS
antibody to visualize chlamydial inclusions and Hoechst dye to visualize nuclear morphology. The micrographs show EGFP fluorescence (green, as a
marker of transfection), Chlamydia (red), and nuclei/DNA (blue). Note the apoptotic morphology in both uninfected and infected cells transfected with
BimS. Similar results were obtained in three separate experiments. (D) Quantification of the results illustrated in C. At least 200 GFP  cells per transfec-
tion were counted, and nuclei were scored as normal or apoptotic. For infected cultures, only cells staining positive for chlamydial antigen were counted.
Data are mean/SD of three independent experiments. (E) Normal Bax activation by BimS in infected cells. Hep2 cells were infected or not and were
cotransfected by electroporation with an EGFP expression plasmid as a marker, and either empty vector or a BimS expression vector 10 h later. 16 h later,
cells were stained for active Bax and analyzed by flow cytometry. The histograms show expression of active Bax in EGFP  cells. Normal line/shaded
area, empty vector; bold line, BimS expression vector.Chlamydia and BH3-only Protein Bim 910
Chlamydial Infection Blocks UV Light–induced Activation of
Bax/Bak. Cytochrome c release is the result of the activa-
tion of Bax/Bak (these two proteins probably act in the
same way and can replace each other; reference 26). Bax/
Bak are present in the cytosol and during the induction of
apoptosis, translocate to the mitochondrial membrane (27,
28). This activation of Bax/Bak involves a conformational
change that can be specifically detected by using antibodies
directed against an epitope that is only exposed during acti-
vation (19, 29). Cells were infected and UV irradiated, and
the activation of Bax/Bak was analyzed by staining with
the activation-specific antibodies. Flow cytometry showed
that UV irradiation induced positive staining for both Bax
(Fig. 2 A, left) and Bak (Fig. 2 A, right) in a high propor-
tion of noninfected HeLa cells, but not in C. trachomatis–
infected cells. This inhibition was still seen at late stages of
the replicative cycle (Fig. 2 A). Infection with the more
virulent species Chlamydia caviae has been found to cause
the activation of Bax in infected cells (30). We did not ob-
serve such activation with C. trachomatis with either Bak or
Bax (Fig. 2), suggesting species-specific differences (the re-
sults from later time points should be interpreted with cau-
tion, however, as at these points the cells are strongly dis-
torted by the chlamydial inclusion, which might impede
staining). Staining for active Bax and the mitochondrial
marker MitoTracker Green FM and analysis by confocal la-
ser scanning gave a positive staining and colocalization only
in noninfected cells upon treatment with UV light (Fig. 2
C, left). HeLa cells were further infected with a low dose of
Chlamydia (MOI: 0.5), UV irradiated, and subjected to
anti-active Bax staining. Costaining for chlamydial LPS
showed that Bax activation was blocked only in infected
cells (Fig. 2 C, right). There was no difference in Bax/Bak
protein expression in infected versus noninfected cells, as
detected by Western blotting (Fig. 2 B). These results indi-
cate that infection with C. trachomatis blocks apoptosis up-
stream of Bax activation.
Chlamydia-infected Cells Retain Sensitivity to BimS- and
Puma-induced Cell Death. The above data show, at least in
part, that the Bim-dependent, UV-induced activation of
Bax is prevented in cells infected with Chlamydia. Although
their activation was prevented, the protein levels of Bax
and Bak did not change during infection (Fig. 2 B). This
suggested that either active Bim was unable to activate Bax,
as would be the case in the presence of high levels of Bcl-2
or a similar protein, or that no active Bim was generated in
infected cells. To distinguish between these possibilities,
Bim was directly expressed in infected cells. At least three
isoforms of Bim exist, all of which promote apoptosis (31).
BimEL and BimL are present in normal cells (in HeLa and
Hep2 cells BimEL is predominant) and are activated by re-
lease from the cytoskeleton. No such posttranslational reg-
ulation is known for BimS. This isoform probably induces
apoptosis directly upon gene induction (24). We trans-
fected HeLa cells with a construct where BimS is placed un-
der the control of a strong promoter and monitored cell
death. Cells were infected or not and cotransfected with a
BimS expression vector or empty vector and a LacZ re-
porter construct to detect transfected cells by  -galactosi-
dase staining (Fig. 3, A and B). Viability of blue (trans-
fected) cells was assessed by morphological criteria (22).
Upon expression of BimS,   80% of transfected normal
HeLa cells were dead. In infected cells, the percentage of
dead cells upon BimS expression was only marginally re-
duced, indicating that chlamydial infection did not protect
against the direct Bim activity. Similar results were seen
when the BH3-only protein Puma was transfected (Fig. 3
B, top, and Fig. S3). To exclude the possibility that trans-
fection killed the cells before Chlamydia had established the
protective mechanism, we further used an inducible ex-
pression system. HeLa cells expressing a tet repressor were
first transfected with the  -galactosidase reporter and a vec-
tor in which either Bim or Puma was placed under a tetra-
cycline-inducible promoter. Cells were then infected with
C. trachomatis, 24 h later expression of Bim or Puma was
induced, and cells were stained after an additional 20 h. As
shown in Fig. 3 B, bottom, the addition of tetracycline
caused cell death in a large proportion of reporter-positive
cells. Infection failed to protect the cells against cell death
caused by the induction of Bim or Puma. Similar results
were observed in experiments of short-term induction of
Bim (6 h of tetracycline; see Fig. S4). Simultaneous detec-
tion of transfection, infection, and nuclear morphology fur-
ther confirmed that BimS induced apoptosis in cells harbor-
ing chlamydial inclusions (Fig. 3, C and D).
The events caused by Bim expression in infected cells
were further investigated. Cells were infected and then
cotransfected with an EGFP expression construct and empty
vector, or a BimS expression construct. After 16 h, cells
were stained for active Bax and analyzed by flow cytome-
try. As shown in Fig. 3 E, coexpression of BimS caused pos-
itive staining for active Bax in EGFP  (i.e., transfected)
cells as compared with transfection with empty vector in
both normal and infected cells. In similar experiments, cells
were infected, transfected with BimS, and stained for cyto-
chrome c. As shown in Fig. S5, BimS caused the release of
cytochrome c also in infected cells.
These data show that active Bim (or Puma) can still cause
apoptosis in infected cells. The inhibition of apoptosis must
therefore involve a block in the activation of Bim/Puma.
Chlamydial Infection Causes the Disappearance of Bim, Puma,
and Bad Proteins. Next, we tested whether chlamyd-
ial infection modified the expression of Bim. mRNA ex-
pression profiling of HeLa cells was performed at 2, 4, 12,
24, 36, and 48 h after infection with either C. trachomatis or
C. pneumoniae (20). Bim mRNA was also analyzed by
quantitative PCR and neither method showed a signifi-
cant reduction during infection. When measured by PCR,
the relative expression was 1.18 at 24 h and 0.9 at 48 h
(expression during infection with C. trachomatis/expression
during mock infection, mean of two experiments). How-
ever, Western blot analysis revealed a near-complete disap-
pearance of Bim protein at 24 h after infection with C. tra-
chomatis. This effect was most pronounced in the epitheloid
cell lines HeLa and Hep2 (derivatives of the natural host
cells of Chlamydia) and the breast carcinoma line MCF-7,Fischer et al. 911
but could also be observed easily in the T cell line Jurkat and
the pro-myeloid cell line HL60 (infection blocks apoptosis in
all of them; Fig. 4 A; reference 16 and not depicted). To de-
termine whether chlamydial protein synthesis was required
for this effect, Hep2 cells were infected in the presence of the
antibiotic rifampin. Under this protocol, the Chlamydia-
induced disappearance of Bim was strongly reduced (the ef-
ficiency of inhibition of the bacterial protein synthesis can be
estimated by monitoring the production of bacterial Hsp60;
Fig. 4, A and B). Bim levels were also investigated in cells in-
fected with C. pneumoniae. As shown in Fig. 4 B, infection
with this species also caused the disappearance of Bim, which
was prevented by rifampin. To investigate whether this dis-
appearance was specific for chlamydial infection or also oc-
curred in other bacterial infections, Hep2 cells and Jurkat
cells were infected with L. pneumophila. Bim protein expres-
sion remained unchanged in Legionella-infected cells. Infec-
tion was controlled by induction of apoptosis by Legionella as
measured as the activation of effector caspases by enzyme as-
say (Fig. 4 C; reference 32).
The disappearance of Bim became noticeable after 14–
16 h of infection with C. trachomatis and was complete after
 24–26 h of infection (Fig. 4 D and not depicted). Bim is
one important member of the BH3-only class of proapop-
totic proteins, and the loss of Bim could explain some but
not all cases where Chlamydia have been found to protect
against apoptosis. A second BH3-only protein whose in
vivo importance has been demonstrated recently by gene
targeting is Puma (33). Puma is known to be regulated
transcriptionally, but can also be detected in normal cells in
culture (34). We analyzed expression of Puma and found
that Puma protein also disappeared during chlamydial in-
fection (Fig. 4 E). The BH3-only protein Bad also disap-
peared upon infection (Fig. 4 E), suggesting that a common
characteristic of BH3-only proteins was targeted.
Chlamydial Infection Targets Bim for Proteasomal Destruc-
tion. These data suggested that Bim was proteolytically
destroyed. The finding that no smaller fragments of Bim
could be detected by Western blotting (not depicted) fur-
ther suggested that Bim was degraded by a proteasomal
activity. The proteasome is a large multisubunit protein
complex that acts to degrade aged and misfolded cellular
proteins. To investigate whether Bim was degraded in the
proteasome, the proteasome inhibitor MG132 was used.
Hep2 cells were infected with C. trachomatis or left unin-
fected and treated with MG132. As shown in Fig. 5 A,
MG132 was able to inhibit Chlamydia-induced degradation
of Bim. Although this finding suggested that Bim was de-
graded by the cellular proteasome, proteasome activity was
not enhanced in cytosolic extracts from infected cells (Fig.
Figure 4. Disappearance of Bim,
Puma, and Bad in Chlamydia-infected
cells. (A) Analysis of SDS and Triton
X-100 extracts of various cell lines.
Cells were infected with C. trachomatis
or left uninfected and harvested after
24 h of infection or as indicated.
SDS extracts from MCF-7 cells (top)
or Triton X-100 extracts (bottom)
were subjected to Western blotting
with antibodies against Bim (isoform
BimEL  is detected) and chlamydial
HSP60 (as control for chlamydial in-
fection). Detection of tubulin served as
a loading control. SDS extracts were
used in the initial experiments to ex-
clude the possibility of Bim degrada-
tion during extraction. (B) Rifampin
treatment prevents degradation of
Bim by both chlamydial species.
Hep2 cells were infected with C.
trachomatis (24 h before analysis) or
C. pneumoniae (as indicated) in the
presence or absence of 10  g/ml
rifampin. Triton X-100 extracts
were analyzed by Western blotting.
(C) No disappearance of Bim is seen
in  Legionella-infected cells. Jurkat
and Hep2 cells were infected with
L. pneumophila for 8 h. Triton X-100
extracts were analyzed by Western
blotting (ns, nonspecific band). Cas-
pase 3–like activity was measured in
cell extracts as described above to
confirm infection, which is known to cause caspase activation. (D) Kinetics of Bim disappearance. At the indicated time points after infection, Triton X-100
extracts of Hep2 cell samples were taken and analyzed by anti-Bim Western blotting. The figure shows typical results from at least three independent ex-
periments. (E) Disappearance of Puma and Bad in infected cells. Hep2 or HeLa cells were infected with C. trachomatis. 24 h later, the expression of Puma
or Bad was assessed by Western blotting.Chlamydia and BH3-only Protein Bim 912
5 B). It is further worth noting that although most cellular
proteins (for instance tubulin, caspases, Bcl-2, and others)
were not degraded in intact cells (11 and not depicted),
proteins other than Bim were digested in cytosolic prepara-
tions. During incubation in vitro, not only exogenously
added, recombinant Bim, but also endogenous tubulin and
a control protein (GST-CED-4) were noticeably degraded.
This degradation was blocked by MG132, but not by a mix
of conventional protease inhibitors, indicating a protea-
some-like activity also in these preparations, albeit less spe-
cific (Fig. 5 C). Zhong et al. (35) could identify a protein
that they named chlamydial proteasome-like activity factor
(CPAF), which is secreted from the inclusion into the host
cell cytosol and causes the degradation of host transcription
factors like RFX5. Under the conditions used here, RFX5
degradation started at 14 h after infection and was complete
at  16 h of infection. The disappearance of Bim started
 2 h later (not depicted).
The BH3 Domain Is Required for Bim Degradation. Next,
an EGFP–BimL fusion protein was expressed by transient
transfection in Hep2 cells. Cells were then infected with C.
trachomatis and analyzed by flow cytometry for EGFP fluo-
rescence. A population of EGFP–BimL-expressing cells was
seen, although the fluorescence intensity was reduced com-
pared with EGFP alone, an effect that may have been due
to Bim toxicity that precluded higher expression. Upon in-
fection, the size of the EGFP  population was strongly re-
duced in the EGFP–BimL, but not the EGFP-expressing
cells (Fig. 6 A). The two inhibitors of proteasome activity,
Figure 5. Bim disappearance requires proteasomal activity. (A) Disap-
pearance of Bim is prevented by a proteasome inhibitor. Hep2 cells were
infected or not with C. trachomatis and treated with 500 nM MG132 and
analyzed by Bim-specific Western blotting. (B) Infection with C. trachomatis
does not increase proteasomal activity. As a measure of proteasomal activity,
cleavage of Suc-LLVY-AMC was analyzed in cytosolic extracts from C.
trachomatis and noninfected cells.  , uninfected;  , C. trachomatis–infected.
The appearance of free AMC over time is shown. (C) Nonspecific pro-
teasomal degradation of proteins in cytosolic extracts from infected cells.
Cytosolic extracts of cells infected with C. trachomatis or not were incu-
bated for 1.5 h at 37 C with GST-BimEL, GST-CED-4, and 500 nM
proteasome inhibitor MG132 as indicated. Western blotting was per-
formed using antibodies against Bim, tubulin, or GST.
Figure 6. The BH3 domain is required for degradation of EGFP–BimL
mutants by chlamydial infection. Hep2 cells were transfected with EGFP
or EGFP–BimL, or its mutants by electroporation. After 4 h, cells were
left uninfected or infected with C. trachomatis. 20 h after infection, cells
were collected for the detection of EGFP fluorescence by flow cytome-
try. (A) Chlamydial infection leads to the proteasome inhibitor–sensitive
disappearance of fluorescence of EGFP–BimL. 500 nM MG132 or 10  M
lactacystin (LC) were added at the time of transfection. Normal line/shaded
area, uninfected cells; bold line, C. trachomatis–infected cells. (B) EGFP–BimL
mutants require the BH3 domain for degradation during chlamydial infec-
tion. Normal line/shaded area, uninfected cells; bold line, C. trachomatis–
infected cells. The figure shows typical results from five independent
experiments. (C) Schematic representation of the constructs used and the
susceptibility to Chlamydia-mediated loss of fluorescence. EGFP was fused
to the NH2 terminus of all Bim mutants. Numbers represent amino acids
in the BimL sequence. Localization of the domains is given at the top.
LC8-BD, dynein light chain 8 binding domain; BH3-D, BH3 domain;
HD, hydrophobic domain. (D) Disappearance of the EGFP–BimL Western
blot band upon infection with C. trachomatis. Hep2 cells were transfected
with EGFP–BimL, and one aliquot was infected with C. trachomatis
(MOI: 3). 20 h later, cells were lysed and EGFP–BimL was detected by
anti-GFP Western blotting. Tubulin served as a loading control. Similar
results were obtained in three experiments.Fischer et al. 913
MG132 and lactacystin, prevented this disappearance (Fig.
6 A) These chemicals are highly toxic to cells, which prob-
ably explains the lower expression of transfected EGFP–
BimL in treated cells. The expression of EGFP alone was
also much reduced in the presence of MG132 (not de-
picted). This suggests that a chlamydial activity is able to
target not only Bim, but also EGFP–BimL for proteasomal
destruction. Disappearance of EGFP–BimL was also seen by
Western blotting (Fig. 6 D).
To map the target site of this chlamydial activity, trun-
cation mutants of EGFP–BimL were generated. The fol-
lowing three domains have been described in the Bim
structure: the BH3 domain (the site similar in all known
BH3-only proteins that is required for their apoptosis-
inducing activity; reference 31); the dynein light chain 8
binding domain, which sequesters Bim to the cytoskeleton
(24); and a hydrophobic domain at the C terminus (31).
We generated constructs for the expression of various trun-
cations of EGFP–BimL, transfected them into Hep2 cells,
and monitored their expression during chlamydial infection
by flow cytometry. Fig. 6 B shows examples of these re-
sults, and Fig. 6 C provides a summary of the results ob-
tained with the constructs tested. Neither the dynein light
chain 8 binding domain (see EGFP–BimL 71–141) nor the
hydrophobic domain (EGFP–BimL 2–106) were required
for the destruction of the fusion protein. However, all con-
structs that encompassed the BH3 domain appeared to be
degraded upon infection (Fig. 6, B and C). The degrada-
tion of a mutant that lacked the five COOH-terminal
amino acids of the BH3 domain (EGFP–BimL 2–101) was
somewhat intermediate. These results strongly suggest that
an activity is generated in cells infected with Chlamydia that
attacks the BH3-domain of Bim, which thereby leads to
the proteasomal destruction of the protein and the protec-
tion of the infected cells against apoptosis.
Discussion
The ability of Chlamydia to protect an infected host cell
against experimental stimuli to apoptosis is well established.
Here, we describe the following mechanism that very
likely accounts for this protection: a chlamydial factor tar-
gets, upon recognition of a region around its BH3 domain,
the proapoptotic protein Bim for proteasomal destruction.
This process requires bacterial protein synthesis and oper-
ates during infection with both chlamydial species, C. tra-
chomatis and C. pneumoniae. Both species have previously
been found to protect against apoptosis in an, as far as in-
vestigated, identical manner. The direct expression of Bim
under a strong promoter was still able to kill infected cells,
indicating that the apoptosis pathway downstream of Bim is
intact and that loss of Bim is indeed functionally relevant
for the inhibition of apoptosis. Similar results were ob-
tained for Puma. Puma protein disappeared during infec-
tion and infection did not protect cells against Puma over-
expression. Furthermore, Bad protein also disappeared.
Because Puma and Bad also have an active BH3 domain,
this suggests that they are targeted by the same mechanism
as Bim.
Chlamydial infection can protect a host cell against a
large number of stimuli. Chlamydia did not afford protec-
tion against the one stimulus tested that does not involve
mitochondrial cytochrome c release, which is death recep-
tor– (CD95) dependent apoptosis induction in so-called
type I cells (16), supporting the concept of a block con-
fined to mitochondrial apoptosis. Apoptosis induced by all
the stimuli against which protection by Chlamydia has been
reported is also inhibited by Bcl-2. The molecular function
of Bcl-2 is still somewhat under debate, but the most plau-
sible role appears to be connected to its ability to bind and
sequester active BH3-only proteins (15).
The allocation of apoptotic stimuli to BH3-only proteins
is incomplete. Among the stimuli inhibited by chlamydial
infection, UV irradiation is mediated by Bim and possibly
Bmf (36), etoposide at least in part by Puma (33), stauro-
sporine by Bim and Puma (25, 33), and TNF and CD95
signal via Bid cleavage (where a mitochondrial contribu-
tion is required; references 37 and 38). Our data suggest a
model that accounts for the far-reaching antiapoptotic ef-
fect of Chlamydia. All BH3-only proteins share the BH3
domain, whose presence is required for the induction of
apoptosis. Because the chlamydial activity targets this do-
main in the Bim protein, all BH3-only proteins might be
subjected to proteasomal destruction. This hypothesis was
tested on the BH3-only proteins Puma and Bad, which
were also found to disappear during chlamydial infection.
All of the following proteins of the apoptosis pathway we
have investigated do not change in expression: Bax, Bak
(above), Bcl-2, Bcl-x, Mcl-1, Bid, caspase 3, caspase 8, cas-
pase 9, Apaf-1, Hsp70, and cytochrome c (11, 16, and not
depicted). Up-regulation of the antiapoptotic protein C-IAP2
has been reported during chlamydial infection (39). How-
ever, IAP act at the level of caspases and, accordingly, our
results do not support a role for IAP in inhibition against
apoptosis by Chlamydia.
Genetically modified mice lacking either Bim (25) or
Puma (33) show a clear protection against some, but not
all, apoptotic stimuli. No double mutant mice have been
tested, but the combined deficiency of Bim and Puma
might well explain the greater share of apoptosis protection
of Chlamydia-infected cells. During CD95 signaling, cas-
pase 8 activation and Bid cleavage were unaffected by
chlamydial infection (16). Bid is present in an inactive state
and is activated by cleavage through caspase 8. Accord-
ingly, the BH3-domain in Bid is normally inactive and
only exposed by this cleavage event (40). Therefore, it
might be speculated that the active Bid (tBid), but not the
inactive form, is also recognized via its BH3 domain and
targeted for destruction, which would explain the protec-
tion against CD95-induced apoptosis (the antibody used to
detect Bid in the above study did not recognize tBid). Such
a general BH3-targeting approach of Chlamydia would ex-
plain the almost general protection of infected cells against
apoptotic stimuli.Chlamydia and BH3-only Protein Bim 914
We still do not know what the chlamydial effector is and
how degradation is achieved. The inhibition of bacterial
protein synthesis with rifampin prevented the disappear-
ance (above) and precluded the development of protection
against apoptosis (11). Most likely, this means that rifampin
inhibits the production of the chlamydial BH3-only, pro-
tein-degrading factor. The sensitivity to MG132 and lacta-
cystin indicates the involvement of a proteasomal activity
and immediately suggests targeting to the cellular protea-
some. However, a chlamydial factor has been purified
and partially characterized, named CPAF. The activity of
CPAF has been shown to be both necessary and sufficient
to cause degradation of cellular transcription factors such as
RFX5, even when purified recombinant proteins were
used (35). RFX5 degradation slightly preceded Bim degra-
dation during chlamydial infection. It is conceivable that
CPAF also mediates degradation of BH3-only proteins.
How CPAF works on a molecular level is still unclear, but
it is also inhibited by inhibitors of the proteasome. Recog-
nition by the proteasome requires modification of a protein
by ligation with the abundant small cellular protein ubiq-
uitin. Ubiquination involves a series of molecular interac-
tions with ubiquitin-transferring enzymes and factors that
convey specificity (41). Bim is targeted at an internal struc-
ture and its degradation is probably complete because no
fragments could be detected by Western blotting and be-
cause the fluorescence of the attached EGFP also disap-
peared in a lactacystin/MG132-sensitive manner. There-
fore, it is possible that the chlamydial activity causes a
modification of Bim, which then leads to the destruction
by the cellular proteasome. Interference with the cellular
ubiquitination/SUMOylation system has been described by
an effector protein from Yersinia (42). Although mechanism
and effect here appear to be opposite (disruption of protea-
somal targeting), it provides an example of where bacteria
use the strategy of interfering with this host cell pathway.
Inhibition of apoptosis in infected cells is a mechanism
that is often used by viruses. Many viruses carry genes
whose products interfere with the host cell’s apoptosis ma-
chinery (43, 44). Chlamydia share a virus’ need for integrity
of the host cell. They differ in that unlike Chlamydia, vi-
ruses pick up their genetic material from host cells. It is in
accordance with this model that Chlamydia use a mecha-
nism to inhibit apoptosis that is not found as a regulatory
means in host cells.
It has been suggested that at later stages of chlamydial in-
fection, apoptosis is induced through the activation of Bax
(30) and the clearance of Chlamydia during vaginal infection
of mice was accelerated in mice lacking Bax (45). Experi-
mentally, Bax could directly (in the absence of BH3-only
proteins) be activated through changes in the intracellular
milieu such as pH changes or oxidative stress (46, 47). If this
occurred at late stages of the infection and led to the uptake
of the infected dead cell by phagocytes or surrounding cells,
such a mechanism might aid the spreading of the infection.
Why do Chlamydia possess the ability to block cell death?
Obviously, there is no need for Chlamydia to protect the
cell against stimuli like staurosporine. An antiapoptotic ca-
pacity only makes sense if there is apoptosis that occurs
during infection and has to be inhibited. It could be argued
that Chlamydia need to prolong the lifespan of the host cell;
however, the natural host cells of Chlamydia, epithelial
cells, probably live longer than a normal replication cycle
would take. To us, it appears more likely that Chlamydia
also have the potential to induce apoptosis. The cell is
probably able to pick up on the presence of Chlamydia and
undergo apoptosis. It has been shown that the development
of the chlamydial inclusion involves restructuring of the
cytoskeleton, including microtubular components (see for
instance reference 17). Because Bim is sequestered to the
cytoskeleton and initiates apoptosis upon its release from
this location, Bim release might be the defense mechanism
that a cell uses against chlamydial infection and that has to
be overcome by the degradation of Bim.
It is a plausible speculation that the inhibition of apopto-
sis is important for the growth of the bacteria. Most
chlamydial infections clear spontaneously, but there is evi-
dence of chronic infections that may even occur in and
contribute to the development of atherosclerotic lesions
(48). In vitro studies further suggest that chronic infections
might be insensitive to antibiotics (49). Therapies directed
at an interference with chlamydial antiapoptotic activities
could therefore turn out helpful to prevent sequelae of pro-
tracted infections with these bacteria.
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